胰岛素瘤检测与手术规划:5.0T MRI与3.0T MRI及MDCT的比较研究
该研究纳入40例高度怀疑胰岛素瘤的患者,比较5.0T MRI、3.0T MRI和MDCT对胰岛素瘤的检出及肿瘤-胰管关系评估能力。结果显示5.0T MRI在图像质量、病灶-胰腺对比度、肿瘤检出率及肿瘤-胰管关系评估可行性上优于3.0T MRI和MDCT;肿瘤-胰管距离可预测剜除术后临床相关术后胰瘘(AUC 0.79)。
要点
- 5.0T MRI对胰岛素瘤的检出率高于3.0T MRI(100% vs 92.0%,p<0.05)。
- 5.0T MRI评估肿瘤-胰管关系的可行性高于3.0T MRI和MDCT(93.2%、64.0%、52.3%,p<0.05)。
- 肿瘤-胰管距离可预测剜除术后临床相关术后胰瘘(AUC 0.79,p=0.01)。
核心结论
- 与3.0T MRI和MDCT相比,5.0T MRI在检测胰岛素瘤和评估肿瘤-胰管关系方面表现出一定优势。
研究设计与样本
- 连续纳入2021年10月至2024年2月高度怀疑胰岛素瘤的患者40例(男14例,平均年龄46.4±16.5岁),术前接受5.0T MRI,以及3.0T MRI或MDCT检查;由三名观察者评估图像质量、病灶-胰腺对比度、主胰管清晰度及肿瘤-胰管关系。
诊断标准与关键数值
- 5.0T MRI的观察者内和观察者间一致性为良好至优秀;5.0T MRI在T1WI和DWI上的主观和客观图像质量显著高于3.0T(p<0.05);5.0T各序列病灶-胰腺对比度均优于3.0T(p<0.05);同时接受5.0T和3.0T MRI的患者中,5.0T MRI肿瘤检出率100%,3.0T MRI为92.0%(p<0.05);肿瘤-胰管关系评估可行性5.0T为93.2%、3.0T为64.0%、MDCT为52.3%(p<0.05);肿瘤-胰管距离预测剜除术后临床相关术后胰瘘的ROC曲线下面积为0.79(p=0.01)。
临床应用与阅片要点
- 作者认为,5.0T MRI在检测胰岛素瘤和评估肿瘤-胰管关系方面可能优于3.0T MRI和MDCT;肿瘤-胰管距离可用于预测剜除术后临床相关术后胰瘘风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To compare the ability among 5.0T MRI, 3.0T MRI and MDCT in identifying insulinomas and determining the tumor-to-duct relationship.
METHODS: A consecutive series of patients highly suspected of insulinomas were enrolled between October 2021 and February 2024, who underwent 5.0T MRI preoperatively, as well as 3.0T MRI or MDCT. The subjective and objective image quality, lesion-to-pancreas contrast, clarity of main pancreatic duct (MPD) and tumor-to-duct relationship at 5.0T, 3.0T MRI and MDCT were evaluated by three observers. The correlation between tumor-duct distance and clinically relevant postoperative pancreatic fistula (CR-POPF) risk was analyzed.
RESULTS: Forty patients (14 men; mean age, 46.4 ± 16.5 years) with insulinomas were included in this study. 21 of them underwent both 5.0T and 3.0T MRI; and 38 of them underwent 5.0T MRI and MDCT. The intra- and inter-observer agreement of 5.0T MRI were good to excellent. 5.0T showed significantly higher subjective and objective image quality on T1WI and DWI compared to 3.0T (p < 0.05). Lesion-to-pancreas contrast was superior across all sequences at 5.0T compared to 3.0T(p < 0.05). A head-to-head comparison of patients who received both 5.0T and 3.0T MRI demonstrated that tumor detection was superior with 5.0T MRI (5.0T: 100%; 3.0 T: 92.0%, p < 0.05). Feasibility of tumor-to-duct relationship assessment was superior at 5.0T, compared to 3.0T and MDCT (93.2%, 64.0% and 52.3%, respectively, p < 0.05). Tumor-duct distance could predict CR-POPF after enucleation surgery (areas under the ROC curve 0.79, p = 0.01).
CONCLUSION: 5.0T MRI exhibits certain superiority in detecting insulinomas and assessing tumor-to-duct relationship compared to 3.0T MRI and MDCT.
引用
- Xu Q, Zhao H, Gao R, et al. Insulinoma detection and surgery planning: a comparative study of 5.0T MRI versus 3.0T MRI and MDCT. Abdom Radiol (NY). 2024. PMID: 39514101. doi:10.1007/s00261-024-04680-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。